Overview of Dr. Laurence
Dr. Jeffrey Laurence is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 41 years. Dr. Laurence accepts several types of health insurance, listed below. He is one of 378 doctors at New York-Presbyterian Hospital and one of 116 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
520 E 70th St
# Starr
New York, NY 10021Fax+1 212-746-8869
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1979 - 1982
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1976 - 1979
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1976
Certifications & Licensure
- NY State Medical License 1977 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1997
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- 24 citationsPhorbol ester-mediated induction of HIV-1 from a chronically infected promonocyte clone: blockade by protein kinase inhibitors and relationship to tat-directed trans-a...Jeffrey Laurence, Santosh K. Sikder, Sanjiv Jhaveri, Jane E. Salmon
Biochemical and Biophysical Research Communications. 1990-01-15 - 25 citationsEffects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal womenMichael T. Yin, Rozbeh Modarresi, Elizabeth Shane, Francisco Santiago, David C. Ferris
Osteoporosis International. 2011-05-01 - 51 citationsAtypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.Jeffrey Laurence, Hermann Haller, Pier Mannuccio Mannucci, Masaomi Nangaku, Manuel Praga
Clinical Advances in Hematology & Oncology. 2016-11-01
Abstracts/Posters
- Differential Effects of HIV Protease Inhibitors on Release and Activation of Platelet-Derived TGF-_1: Potential Association with HIV-Linked CVDJeffrey Laurence, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Masp-2 Levels Following Allogeneic Hematopoietic Stem Cell Transplantation in Adults: Correlation with Development of a Thrombotic Microangiopathy and Implications for...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Defibrotide Inhibits Endothelial Cell Injury Induced By Plasmas of Patients with Thrombotic Microangiopathies61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
- Using Simple Skin Biopsy, Blood Clots Linked to Covid Can Be EvaluatedJuly 15th, 2022
- Simple Skin Biopsy Can Assess Tissue Damage Related to COVID-19July 15th, 2022
- Covid-19 Patients Benefit from Improved Screening and Treatment of Blood ClotsDecember 10th, 2021
- Join now to see all
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPOFirst Health PPO
Great West PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Multiplan PHCS PPO
MVP Healthcare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: